Akso Health Group
AHG
3 hedge funds and large institutions have $575K invested in Akso Health Group in 2021 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 3 closing their positions.
19% less capital invested
Capital invested by funds: $713K → $575K (-$138K)
50% less funds holding
Funds holding: 6 → 3 (-3)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$46.2K |
| 2 |
HF
HRT Financial
New York
|
-$22K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$4.87K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$4K |
| 5 |
PCM
Penserra Capital Management
Orinda,
California
|
-$2K |
AHG Hedge Fund Activity: Q2 2021 in Review
3 of the 5,768 institutional investors tracked by Wall St. Rank reported a position in Akso Health Group (AHG) for Q2 2021, worth a combined $575K — down 19% from $713K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of AHG and 0 opened new positions — a net loss of 3 holders — while 2 trimmed existing stakes and 0 added.
The largest seller was Renaissance Technologies, cutting an estimated $46.2K.
- 3 institutional investors held Akso Health Group (AHG) as of Q2 2021, down from 6 in Q1 2021.
- Funds reported $575K of Akso Health Group stock for Q2 2021, down 19% quarter-over-quarter.
- 0 funds opened new Akso Health Group positions in Q2 2021 and 3 closed out, a net change of -3 holders.
- The largest Akso Health Group seller in Q2 2021 was Renaissance Technologies, an estimated $46.2K sold.
Based on aggregated 13F filings for Q2 2021.